PD-1/PDL1 pathway in the maintenance of maternal-foetal immunotolerance


Development at 20 Weeks The baby weighs about 10 ounces and is a little more than 6 inches long. Your uterus should be at the level of your belly button. The baby can suck a thumb, yawn, stretch, and make faces. Soon -- if you haven't already -- you'll feel your baby move, which is called "quickening." Source: WebMD

Development at 20 Weeks
The baby weighs about 10 ounces and is a little more than 6 inches long. Your uterus should be at the level of your belly button. The baby can suck a thumb, yawn, stretch, and make faces. Soon — if you haven’t already — you’ll feel your baby move, which is called “quickening.” Source: WebMD

A foetus is a semi-conceptus which survives the maternal immune attack leading to the maintenance of pregnancy to full term. A galore of immune cells are present at the feto- maternal interface and the modulation of immune response at this interface aids in the survival of semi-allogenic foetus. The transmembrane protein, Programmed cell death protein 1 (PD-1) is expressed by a variety of activated immune cells, including T (CD4+, CD8+, NKT-like and regulatory T (Treg)) cells, B cells, monocytes and dendritic cells. Extensive research has shown PD-1 to be involved in T cell homeostasis and along with its ligands helps in the maintenance of peripheral immune tolerance. What is less known is the importance of PD-1/PDL1 pathway in maternal-foetal immunotolerance.

Meggyes et.al in this paper has highlighted the role of PD-1/PDL1 pathway during pregnancy. They recruited healthy women who underwent pregnancy termination for non-medical reasons in the first trimester of their pregnancy. The control group consisted of healthy non-pregnant women. Results revealed an increase in the proportion of decidual immune cells subsets, CD8+ T-, CD56 + NK-, CD56dimNK, and CD56brightNK cells from the decidual tissue compared to the peripheral blood. Decidual CD8+ T, CD4+ T, and NKT-like cells showed an increased expression of PD-1 compared to the periphery. Authors propose that the increase in the expression of PD-1 receptor by the residual CD8+ cells would be to regulate and avoid exaggerated inflammatory effects during pregnancy.

Apart from the expression of PD-1 on the decidual immune cells, authors also analysed the cytotoxic potential of these cells. Results showed a significantly decreased cytotoxic activity by decidual PD-1+ CD8+ T cells compared to the peripheral counterparts. NKG2D, an activation receptor and its co-expression with PD-1 was analysed and it was seen that NKG2D expression was decreased by the PD-1+ CD8+ T subsets in the first trimester compared to non- pregnant condition but the expression level of the decidual counterparts was significantly elevated compared to the periphery. There was decreased cytotoxic activity via decreased CD107a expression by decidual PD-1/NKG2D double positive CD8+ T cells. Authors do suggest that PD-1+ NKG2Dhigh CD8+ T cell interaction via surface NKG2D ligands by the trophoblast could help in the invasion of extravillous trophoblast and may also benefit in preventing microbial infections. Thus, PD-1/PDL1 pathway aids in the maintenance of the immunological environment at the foetal-maternal interface.

Journal article: Meggyes et.al, 2019. The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface. BMC Pregnancy and Childbirth

 

Article by Babita Balakrishnan

 

 
 
 
 
 
 
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineScience Education PrizesElizabeth Glazer Pediatric Aids Foundation
 

Accessibility Toolbar